Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01620853|
Recruitment Status : Completed
First Posted : June 15, 2012
Last Update Posted : February 6, 2015
The purpose of the study is the identification of chromosomal aberrations in non-small cell lung cancer (NSCLC) .
The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classifying ALK FISH stained lung samples.
|Condition or disease|
|Non-small Cell Lung Cancer (NSCLC)|
|Study Type :||Observational|
|Actual Enrollment :||1 participants|
|Official Title:||Concordance Study for Detection of Chromosomal Aberrations Using FISH (ALK Test)in Non-small Cell Lung Cancer (NSCLC)|
|Study Start Date :||May 2012|
|Actual Primary Completion Date :||January 2013|
|Actual Study Completion Date :||January 2013|
- IVD study [ Time Frame: 1 Day ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01620853
|United States, Texas|
|Scott & White Hospital,|
|Temple,, Texas, United States|